Feb 24, 2020
Halozyme Announces CFO Transition
Feb 24, 2020
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
Feb 20, 2020
AbbVie Declares Quarterly Dividend
Feb 19, 2020
AbbVie to Present at the Cowen 40th Annual Health Care Conference
Feb 18, 2020
Synlogic Announces Participation in Upcoming Investor Conferences
Feb 17, 2020
Global Gynecology Drugs Market by Therapeutics, Indication, Distribution Channel and Geography - Forecast to 2025
Feb 13, 2020
Global Anti-Thyroid Drugs Market Research Report 2020 - Mylan, Abbott Labs, GlaxoSmithKline, Merck, and AbbVie are Dominating
Feb 05, 2020
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Jan 28, 2020
ROI in Pharmaceutical R&D: An Assessment of ROI in R&D by Leading Pharmaceutical Companies in the Industry
Jan 27, 2020
Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Jan 27, 2020
Arix Co-founds Quench Bio With Series A Financing
Jan 27, 2020
AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep
Jan 22, 2020
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Jan 14, 2020
Halozyme Provides 2020 Business Update And Financial Guidance
Jan 10, 2020
Technological Advancements Expand Biopharmaceuticals' Production Capabilities
Jan 08, 2020
AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisition
Jan 08, 2020
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Dec 20, 2019
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
Dec 20, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Dec 16, 2019
AbbVie Inc. - Form 8.1 - Statement of Stock Purchase by Director